Four of the FDA\’s warning letters went to companies that jointly produced a product labeled as homeopathic that posed a significant safety risk to consumers because their purportedly sterile products were not shown to be sterile and the fifth letter outlined a company\’s failure to have systems in place to assure proper design, monitoring, and control of manufacturing processes.
Source: News feed